FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder

The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Generic olanzapine tablets will be manufactured by Dr. Reddy's Laboratories Ltd. RDY and Teva Pharmaceuticals USA TEVA. Generic olanzapine orally disintegrating tablets will be manufactured by Apotex Inc., Dr. Reddy's Laboratories Ltd., and Par Pharmaceuticals Inc PRX.